Search

everythinglearnresearchcommunity

for

Search:↓

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

ICP5249 helps hair grow by activating a specific cell pathway.

Blocking casein kinase 1 in skin cells can help melanocyte precursors move better, potentially helping with conditions like vitiligo or gray hair.

Baricitinib may not always prevent relapse in alopecia areata.

Baricitinib-loaded EVs help hair regrowth in alopecia areata by reducing inflammation and promoting hair follicle regeneration.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

New markers and pathways have been found in skin tumors, helping better understand and diagnose them.

Sporadic trichoblastic neoplasms generally don't recur or spread, with one case showing a specific genetic fusion.

A 12-year-old girl was misdiagnosed with alopecia areata but actually had a nevus sebaceus with a genetic mutation.

"Dermatologic Therapy" offers expert treatment info for various skin diseases.

The rash resolved after stopping ponatinib.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Oral 5-alpha-reductase inhibitors for hair loss don't increase heart risk.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Valproic acid is effective for various seizures, but may cause temporary side effects like drowsiness and stomach issues.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

JAK inhibitors may help improve symptoms in adults with APECED.

A patient developed hair loss after hepatitis C treatment with sofosbuvir and ribavirin.